Atea Pharmaceuticals Statistics
Total Valuation
AVIR has a market cap or net worth of $435.51 million. The enterprise value is $216.47 million.
| Market Cap | 435.51M |
| Enterprise Value | 216.47M |
Important Dates
The last earnings date was Wednesday, August 12, 2026, after market close.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
AVIR has 80.20 million shares outstanding. The number of shares has decreased by -6.62% in one year.
| Current Share Class | 80.20M |
| Shares Outstanding | 80.20M |
| Shares Change (YoY) | -6.62% |
| Shares Change (QoQ) | +1.08% |
| Owned by Insiders (%) | 16.10% |
| Owned by Institutions (%) | 67.53% |
| Float | 60.34M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | n/a |
| PB Ratio | 2.13 |
| P/TBV Ratio | 2.13 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 8.13, with a Debt / Equity ratio of 0.00.
| Current Ratio | 8.13 |
| Quick Ratio | 7.80 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -58.14% and return on invested capital (ROIC) is -40.17%.
| Return on Equity (ROE) | -58.14% |
| Return on Assets (ROA) | -36.72% |
| Return on Invested Capital (ROIC) | -40.17% |
| Return on Capital Employed (ROCE) | -89.77% |
| Weighted Average Cost of Capital (WACC) | 5.71% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$3.01M |
| Employee Count | 55 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -6.50M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +55.14% in the last 52 weeks. The beta is 0.27, so AVIR's price volatility has been lower than the market average.
| Beta (5Y) | 0.27 |
| 52-Week Price Change | +55.14% |
| 50-Day Moving Average | 4.79 |
| 200-Day Moving Average | 4.49 |
| Relative Strength Index (RSI) | 63.20 |
| Average Volume (20 Days) | 376,731 |
Short Selling Information
The latest short interest is 7.53 million, so 9.39% of the outstanding shares have been sold short.
| Short Interest | 7.53M |
| Short Previous Month | 7.76M |
| Short % of Shares Out | 9.39% |
| Short % of Float | 12.48% |
| Short Ratio (days to cover) | 19.59 |
Income Statement
| Revenue | n/a |
| Gross Profit | -155.12M |
| Operating Income | -183.27M |
| Pretax Income | -171.79M |
| Net Income | -165.29M |
| EBITDA | -182.86M |
| EBIT | -183.27M |
| Earnings Per Share (EPS) | -$2.10 |
Balance Sheet
The company has $219.47 million in cash and $424,000 in debt, with a net cash position of $219.04 million or $2.73 per share.
| Cash & Cash Equivalents | 219.47M |
| Total Debt | 424,000 |
| Net Cash | 219.04M |
| Net Cash Per Share | $2.73 |
| Equity (Book Value) | 204.16M |
| Book Value Per Share | 2.55 |
| Working Capital | 200.54M |
Cash Flow
| Operating Cash Flow | -152.07M |
| Capital Expenditures | n/a |
| Depreciation & Amortization | 416,000 |
| Net Borrowing | n/a |
| Free Cash Flow | -152.07M |
| FCF Per Share | -$1.90 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
AVIR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 6.62% |
| Shareholder Yield | 6.62% |
| Earnings Yield | -37.95% |
| FCF Yield | -34.92% |
Analyst Forecast
The average price target for AVIR is $9.42, which is 73.48% higher than the current price. The consensus rating is "Buy".
| Price Target | $9.42 |
| Price Target Difference | 73.48% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | n/a |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 1 |